Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFORT-MIBC
NCT04724928Phase 2Recruiting
- Sponsor
- Ghent University Hospital
- Start
- Apr 2021
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Phase 2, open-label trial in muscle-invasive bladder cancer (MIBC) (3 arms), sponsored by Ghent University Hospital. Primary endpoint: Overall Survival at 2 years. Started Apr 2021; status: recruiting.
02
Conditions
muscle-invasive bladder cancer (MIBC)
Beyond the preview
Go deeper on NCT04724928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724928.